FOR HEALTHCARE PROFESSIONALS ONLY
Inflammation Lung COPD

One minute to ignite new thinking in COPD

  1. Article
  2. Campus Sanofi
  3. May 15, 2024
Understanding type 2 inflammation may help shed light on why some patients continue to exacerbate. Watch this video to learn how.
Read more

SANOFI, Kingdom of Saudi Arabia, P.O. Box 9874, Jeddah 21423, K.S.A. Tel: +966-12-669-3318, Fax: +966-12-663-6191 For further medical information, please contact: +966-12-669-3318 or send an email to: ksa.medicalinformation@sanofi.com To report any Product Technical Complaints, kindly contact: Email: quality.greatergulf@sanofi.com In case of any drug related adverse events, please contact: The National Pharmacovigilance Center (NPC): Call Center: 19999, E-mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa/ And Sanofi Pharmacovigilance Department: Phone: +966-544-284-797, E-mail: Ksa_pharmacovigilance@sanofi.com

MAT-BH-2400291/V1/May/2024Last Update: 05/2024